MOZ/KAT6A: a promising target for acute myeloid leukemia therapy-Reference-Cited by-同舟云学术

MOZ/KAT6A: a promising target for acute myeloid leukemia therapy

Published:2020-05 Issue:9 Volume:12 Page:759-761
ISSN:1756-8919
Container-title:Future Medicinal Chemistry
language:en
Short-container-title:Future Medicinal Chemistry

Author:

Zhou Chongchen¹,Liu Wei¹,Duan Yongtao¹

Affiliation:

1. Henan Provincial Key Laboratory of Children’s Genetics & Metabolic Diseases, Children’s Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China

Publisher

Future Science Ltd

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.future-science.com/doi/pdf/10.4155/fmc-2020-0047

Reference20 articles.

1. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics

2. Precision Tumor Medicine and Drug Targets

3. Histone acetyltransferase inhibitors: where art thou?

4. Discovery of Benzoylsulfonohydrazides as Potent Inhibitors of the Histone Acetyltransferase KAT6A

5. The Diverse Biological Roles of MYST Histone Acetyltransferase Family Proteins

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KAT6A/YAP/TEAD4 pathway modulates osteoclastogenesis by regulating the RANKL/OPG ratio on the compression side during orthodontic tooth movement;Progress in Orthodontics;2024-08-12

2. ERα status of invasive ductal breast carcinoma as a result of regulatory interactions between lysine deacetylases KAT6A and KAT6B;2024-07-26

3. A case of KAT6A syndrome with a newly discovered mutation in the KAT6A gene, mainly manifested as bone marrow failure syndrome;Hematology;2023-03-07

4. The histone acetyltransferase KAT6A is recruited to unmethylated CpG islands via a DNA binding winged helix domain;Nucleic Acids Research;2022-12-20

5. Effects of Injury Severity and Brain Temperature on KAT6A Expression after Traumatic Brain Injury in Rats;BIO Integration;2022-09-16